Pulmonx Corp Stock Buy Hold or Sell Recommendation
| LUNG Stock | USD 8.68 0.24 2.69% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Pulmonx Corp is 'Strong Sell'. Macroaxis provides Pulmonx Corp buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LUNG positions.
Check out Pulmonx Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide. Note, we conduct extensive research on individual companies such as Pulmonx and provide practical buy, sell, or hold advice based on investors' constraints. Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Pulmonx |
Execute Pulmonx Corp Buy or Sell Advice
The Pulmonx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pulmonx Corp. Macroaxis does not own or have any residual interests in Pulmonx Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pulmonx Corp's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Pulmonx Corp Trading Alerts and Improvement Suggestions
| Pulmonx Corp is way too risky over 90 days horizon | |
| Pulmonx Corp appears to be risky and price may revert if volatility continues | |
| Pulmonx Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 68.67 M. Net Loss for the year was (60.84 M) with profit before overhead, payroll, taxes, and interest of 62 M. | |
| Pulmonx Corp currently holds about 162.09 M in cash with (37.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.35. | |
| Pulmonx Corp has a poor financial position based on the latest SEC disclosures | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Pulmonx Full Year 2024 Earnings Beats Expectations |
Pulmonx Corp Returns Distribution Density
The distribution of Pulmonx Corp's historical returns is an attempt to chart the uncertainty of Pulmonx Corp's future price movements. The chart of the probability distribution of Pulmonx Corp daily returns describes the distribution of returns around its average expected value. We use Pulmonx Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pulmonx Corp returns is essential to provide solid investment advice for Pulmonx Corp.
| Mean Return | 0.65 | Value At Risk | -5.01 | Potential Upside | 5.76 | Standard Deviation | 5.13 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pulmonx Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Pulmonx Stock Institutional Investors
| Shares | Rock Springs Capital Management Lp | 2024-12-31 | 772.2 K | State Street Corp | 2024-12-31 | 759.3 K | Braidwell Lp | 2024-12-31 | 752.5 K | Franklin Resources Inc | 2024-12-31 | 576.3 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 408 K | D. E. Shaw & Co Lp | 2024-12-31 | 392.8 K | Pura Vida Investments, Llc | 2024-12-31 | 387.2 K | Northern Trust Corp | 2024-12-31 | 372.7 K | Charles Schwab Investment Management Inc | 2024-12-31 | 315.5 K | Fmr Inc | 2024-12-31 | 5.9 M | Primecap Management Company | 2024-12-31 | 5.5 M |
Pulmonx Corp Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (5.0M) | (6.5M) | (3.6M) | 918K | 826.2K | 867.5K | |
| Change In Cash | 217.0M | (83.1M) | (46.7M) | (18.2M) | (16.4M) | (15.5M) | |
| Net Borrowings | 6M | 33.0M | (41K) | (140K) | (161K) | (153.0K) | |
| Depreciation | 483K | 867K | 1.5M | 1.5M | 1.8M | 1.9M | |
| Capital Expenditures | 911K | 3.7M | 1.3M | 807K | 928.1K | 802.6K | |
| Net Income | (32.2M) | (48.7M) | (58.9M) | (60.8M) | (54.8M) | (52.0M) | |
| Change To Netincome | 1.9M | 1.9M | 11.7M | 17.0M | 19.6M | 20.6M | |
| End Period Cash Flow | 231.8M | 148.7M | 102.0M | 83.8M | 96.4M | 93.5M | |
| Investments | 12.7M | (42.6M) | (2.9M) | 21K | 18.9K | 19.8K | |
| Free Cash Flow | (31.5M) | (45.1M) | (46.4M) | (38.4M) | (34.6M) | (36.3M) | |
| Other Non Cash Items | 5.5M | 2.5M | 2.8M | 2.1M | 2.5M | 2.5M |
Pulmonx Corp Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pulmonx Corp or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pulmonx Corp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pulmonx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.64 | |
β | Beta against Dow Jones | -0.7 | |
σ | Overall volatility | 5.32 | |
Ir | Information ratio | 0.12 |
Pulmonx Corp Volatility Alert
Pulmonx Corp currently demonstrates below-average downside deviation. It has Information Ratio of 0.12 and Jensen Alpha of 0.64. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Pulmonx Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Pulmonx Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Pulmonx Corp Fundamentals Vs Peers
Comparing Pulmonx Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pulmonx Corp's direct or indirect competition across all of the common fundamentals between Pulmonx Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pulmonx Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pulmonx Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing Pulmonx Corp by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pulmonx Corp to competition |
| Fundamentals | Pulmonx Corp | Peer Average |
| Return On Equity | -0.55 | -0.31 |
| Return On Asset | -0.21 | -0.14 |
| Profit Margin | (0.67) % | (1.27) % |
| Operating Margin | (0.56) % | (5.51) % |
| Current Valuation | 307.22 M | 16.62 B |
| Shares Outstanding | 39.49 M | 571.82 M |
| Shares Owned By Insiders | 4.98 % | 10.09 % |
| Shares Owned By Institutions | 94.24 % | 39.21 % |
| Number Of Shares Shorted | 1.22 M | 4.71 M |
| Price To Book | 4.10 X | 9.51 X |
| Price To Sales | 4.09 X | 11.42 X |
| Revenue | 68.67 M | 9.43 B |
| Gross Profit | 62 M | 27.38 B |
| EBITDA | (55.09 M) | 3.9 B |
| Net Income | (60.84 M) | 570.98 M |
| Cash And Equivalents | 162.09 M | 2.7 B |
| Cash Per Share | 4.35 X | 5.01 X |
| Total Debt | 41.42 M | 5.32 B |
| Debt To Equity | 0.15 % | 48.70 % |
| Current Ratio | 9.43 X | 2.16 X |
| Book Value Per Share | 2.17 X | 1.93 K |
| Cash Flow From Operations | (37.61 M) | 971.22 M |
| Short Ratio | 5.56 X | 4.00 X |
| Earnings Per Share | (1.44) X | 3.12 X |
| Price To Earnings To Growth | (0.42) X | 4.89 X |
| Target Price | 11.67 | |
| Beta | 0.64 | -0.15 |
| Market Capitalization | 342.75 M | 19.03 B |
| Total Asset | 177.78 M | 29.47 B |
| Retained Earnings | (411.16 M) | 9.33 B |
| Working Capital | 127.27 M | 1.48 B |
| Net Asset | 177.78 M |
Note: Disposition of 2221 shares by Glendon French of Pulmonx Corp at 6.5 subject to Rule 16b-3 [view details]
Pulmonx Corp Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pulmonx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Pulmonx Corp Buy or Sell Advice
When is the right time to buy or sell Pulmonx Corp? Buying financial instruments such as Pulmonx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Pulmonx Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials ETFs Thematic Idea Now
Financials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Pulmonx Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Revenue Per Share | Quarterly Revenue Growth 0.233 | Return On Assets | Return On Equity |
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.